API

API

SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India with world-class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards

SMS has over the years developed tremendous manufacturing facilities to suit its style of operations and to meet the requirements of USFDA and WHO cGMP. A total of 4 facilities are being presently operated.

We have capabilities in wide range of APIs / intermediates and have handled varied process reactions and reactor volumes up to 15KL

Our commitment to quality and productivity is reflected in the implementation of total quality management processes at every stage of the manufacturing life cycle which is acknowledged by our ever expanding list of clientele globally.

Vizag Unit

0 KL
Cool Number

Key Products

Ibuprofen, Tenofavir, Ranolazine, Levetiracetam, Lamuvidine, Lamotrigine, Efavirenz, Sitagliptin etc.

Regulatory Approvals

USFDA, KFDA, CDSCO, PMDA

USPs

3 times approved by USFDA.

Bachupally Unit

0 KL
Cool Number

Key Products

Famotidine, Rizatriptan Benzoate, Tadalafil, Sumatriptan Succinate, Itraconazole, Eletriptan HBr etc.

Regulatory Approvals

USFDA, EUGMP, KFDA, CDSCO, PMDA

USPs

5 times approved by USFDA.

Bachupally Unit

Building on our strong capabilities in product development and manufacturing, this unit has developed a wide range of in-house APIs and intermediates.

We focus on chemistry where we can make a difference and combine innovation with efficiency to develop cost-effective and hence affordable processes. We regularly invest in building capacities to ensure reliable and sustained supply.​

We offer our globally compliant cGMP facilities, along with our chemistry expertise, to customers for development and manufacturing of APIs and intermediates. We are already a preferred to several customers, owing to our stringent quality and SHE systems, wide operability range. With proven capabilities, we provide end-to-end API solutions to global markets that meet and exceed the quality, regulatory and requirements as well as cost targets.

INVESTORS DESK